MWVC
NVO

Morgens Waterfall Vintiadis & Co’s Novo Nordisk NVO Stock Holding History

Morgens Waterfall Vintiadis & Co’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,000
Closed -$3.57M – 28
2024
Q3 		$3.57M Hold
30,000
– – 2.77% 17
2024
Q2 		$4.28M Sell
30,000
-7,000
-19% -$928K 3.26% 15
2024
Q1 		$4.75M Buy
37,000
+1,300
+4% +$155K 3.28% 13
2023
Q4 		$3.69M Sell
35,700
-800
-2% -$79.1K 2.74% 19
2023
Q3 		$3.32M Buy
36,500
+500
+1% +$44K 2.68% 19
2023
Q2 		$2.91M Buy
+36,000
New +$2.94M 2.07% 22

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Morgens Waterfall Vintiadis & Co's NVO Position: Q4 2024 in Review

Morgens Waterfall Vintiadis & Co sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 30,000 shares — an estimated $3.57M sold.

Morgens Waterfall Vintiadis & Co first reported a position in NVO in Q2 2023 and held it in 6 quarters. The position peaked at $4.75M in Q1 2024. 1,664 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Morgens Waterfall Vintiadis & Co reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Morgens Waterfall Vintiadis & Co sold 30,000 Novo Nordisk shares in Q4 2024, an estimated $3.57M.
  • Morgens Waterfall Vintiadis & Co first reported a position in Novo Nordisk in Q2 2023 and held it in 6 quarters.
  • Morgens Waterfall Vintiadis & Co's Novo Nordisk position peaked at $4.75M in Q1 2024.
  • 1,664 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q4 2024, filed 14 Feb 2025.